glp 1 and osteoporosis AAOS | A new study presented at #AAOS2026 revealed GLP-1 use may be linked to a 29% higher risk of after five years. As use of Figure 2 from Gut Hormones

Another study showed that glutathione stores were increased with the use of a liposomal product

Preliminary data published in June 2023 also suggests that GLP-1 drugs 'could modulate crucial pathways in the pathogenesis of inflammatory bowel disease (IBD), such as chronic inflammation circuits, intestinal tight junctions, and gut microbiome dysbiosis, setting the stage for human trials to investigate the role of these agents in the treatment of IBD among people with or without diabetes and obesity' (Arvanitakis, Theocharis, Popovic

[Abstract] Toxics

16 Storage and Transportation Store in a tightly sealed container